Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LRRK2 | Q5S007 | 11/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | SLCO1B1 | Q9Y6L6 | 2/20 | 0.58 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | APP | P05067 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 1/20 | 0.44 |
| ▸ | PPARD | Q03181 | 1/20 | 0.44 |
| ▸ | PPARA | Q07869 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1318286 | 0.88 | LRRK2 (0.64) | LRRK2CYP3A4SLCO1B1MRGPRX4HSD17B10 | |
| SCHEMBL552011 | 0.87 | LRRK2 (0.62) | LRRK2CYP3A4SLCO1B1MRGPRX4HSD17B10 | |
| SCHEMBL1317670 | 0.86 | LRRK2 (0.66) | LRRK2CYP3A4SLCO1B1MRGPRX4HSD17B10 | |
| SCHEMBL1316024 | 0.85 | LRRK2 (0.57) | LRRK2CYP3A4SLCO1B1KCNH2 | |
| SCHEMBL1316798 | 0.85 | LRRK2 (0.57) | LRRK2CYP3A4SLCO1B1MEN1KMT2A | |
| SCHEMBL552232 | 0.84 | LRRK2 (0.63) | LRRK2CYP3A4SLCO1B1MRGPRX4HSD17B10 | |
| SCHEMBL1318379 | 0.82 | LRRK2 (0.53) | LRRK2CYP3A4SLCO1B1MEN1KMT2A | |
| SCHEMBL1315941 | 0.82 | LRRK2 (0.53) | LRRK2CYP3A4SLCO1B1SMN1; SMN2KDM4E | |
| SCHEMBL19381144 | 0.78 | CCR5 (0.62) | LRRK2CYP3A4SLCO1B1HSD17B10MEN1 | |
| SCHEMBL1316513 | 0.77 | LRRK2 (0.63) | LRRK2CYP3A4SLCO1B1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8110570-B2 | Modulators of acetyl-coenzyme A carboxylase and methods of use thereof | CROPSOLUTION, INC. (US) | 2012-02-07 | — | — | US | disclosed |
| US-20100009982-A1 | Modulators of Acetyl-Coenzyme A Carboxylase and Methods of Use Thereof | CROPSOLUTION, INC. | 2010-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100009982-A1 | Modulators of Acetyl-Coenzyme A Carboxylase and Methods of Use Thereof | ACACA, ACAT1, ACACB | LRRK2 2106/4885CYP3A4 1282/4885SLCO1B1 4009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.